Neuropsychiatric Sequelae Virtual Curriculum Series: Agitation, Depression, and Pseudobulbar Affect
Cost: Free
View Offer chevron_rightDetails
Neuropsychiatric Sequelae Virtual Curriculum Series: Agitation, Depression, and Pseudobulbar Affect consists of two sections: Mechanisms and Management of Agitation in Alzheimer’s Disease and Challenges in Managing Treatment-Resistant Depression.
After viewing Neuropsychiatric Sequelae Virtual Curriculum Series, you will be better able to:
• Identify different and various forms of agitation among patients with Alzheimer’s disease (AD).
• Review proposed mechanisms underlying agitation in AD and how pharmacologic agents may affect them
• Evaluate body of evidence of current and emerging pharmacologic agents for the management of agitation/aggression in patients with AD
Target Audiences:
This program is intended for US-based neurologists, psychiatrists, geriatricians, primary care clinicians and health care providers involved in the care of patients with neuropsychiatric sequelae who may be suffering from agitation as a result of Alzheimer’s disease (AD).